Reactions Weekly

, Volume 1633, Issue 1, pp 63–63 | Cite as


Pneumocystis jirovecii pneumonia: 5 case reports
Case report


  1. Hardak E, et al. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/ sulfamethoxazole: A single-center experience. Acta Haematologica 127: 110-114, No. 2, Feb 2012. Available from: URL: - Israel

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations